Industry News

      Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®

      REYKJAVIK, Iceland--(BUSINESS WIRE)--Alvotech Holdings S.A. (“Alvotech”), a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, today...

      Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022

      IRVING, Texas--(BUSINESS WIRE)--Ontada®, a McKesson business focused on provider technology and actionable real-world research, education and evidence in oncology, announced the acceptance of seven...

      Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases

      REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nuvig Therapeutics, Inc., announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and...

      Recent Articles

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.